News
Archive
Paragraf named Business of the Year in Cambridge glory parade
VUV Analytics Announces Publication of ASTM D8519-23
Ventyx Biosciences announces initiation of dosing in a Phase 1 trial of VTX3232, a novel CNS-penetrant NLRP3 inhibitor
Ventyx Biosciences announces completion of enrollment of the Phase 2 trial of VTX002 in ulcerative colitis and the Phase 2 trial of VTX958 in plaque psoriasis
Novadip Biosciences SA announces first pediatric patient with congenital pseudoarthrosis of the tibia undergoes implantation with NVD-003, an autologous tissue regeneration product, in Phase 1b/2a US/EU clinical trial
Trellis Bioscience announces positive interim Phase 1 results for TRL1068, a novel native human monoclonal antibody which reduces bacterial biofilm burden in chronic prosthetic joint infections
Back To News
March 2, 2018
Editor’s Corner—This is why the wireless industry is running from cRAN to vRAN to oRAN
Dali Wireless announced the launch of its second-generation Dali Matrix virtual Fronthaul Interface, which the company said is part of the oRAN effort.
The post Editor’s Corner—This is why the wireless industry is running from cRAN to vRAN to oRAN appeared first on Dali Wireless.